Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Intravenous Administration
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: Heparin, Low-Molecular-Weight
- First Posted Date
- 2012-09-25
- Last Posted Date
- 2022-10-31
- Lead Sponsor
- Azidus Brasil
- Target Recruit Count
- 32
- Registration Number
- NCT01692171
- Locations
- 🇧🇷
LAL Clinica, Valinhos, Sao Paulo, Brazil
Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Subcutaneous Single Dose
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: Heparin, Low-Molecular-Weight
- First Posted Date
- 2012-09-25
- Last Posted Date
- 2022-10-31
- Lead Sponsor
- Azidus Brasil
- Target Recruit Count
- 36
- Registration Number
- NCT01692158
- Locations
- 🇧🇷
LAL Clinica, Valinhos, Sao Paulo, Brazil
Clinical Assessment Of Association Pharmacokinetics Atorvastatin + Losartana + Hydrochlorothiazide
Phase 1
Completed
- Conditions
- Healthy Subjects
- Interventions
- First Posted Date
- 2012-09-25
- Last Posted Date
- 2022-10-31
- Lead Sponsor
- Azidus Brasil
- Target Recruit Count
- 90
- Registration Number
- NCT01692717
- Locations
- 🇧🇷
LAL Clínica Pesquisa e Desenvolvimento Ltda, Valinhos, São Paulo, Brazil
PK and PD Crossover Study After Single Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant Epoetin and Eprex, in Healthy Subjects.
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: Epoetin Alfa
- First Posted Date
- 2012-09-14
- Last Posted Date
- 2022-10-31
- Lead Sponsor
- Azidus Brasil
- Target Recruit Count
- 28
- Registration Number
- NCT01685333
- Locations
- 🇧🇷
LAL Clinica, Valinhos, Sao Paulo, Brazil
PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: Epoetin Alfa
- First Posted Date
- 2012-09-14
- Last Posted Date
- 2022-10-28
- Lead Sponsor
- Azidus Brasil
- Target Recruit Count
- 80
- Registration Number
- NCT01685359
- Locations
- 🇧🇷
LAL Clinica, Valinhos, Sao Paulo, Brazil
Clinical Efficacy of Postpartum Immunization of Rh and Coombs Negative Women With Sensitization Risk.
Phase 3
Suspended
- Conditions
- Pregnancy; Fetomaternal Hemorrhage
- Interventions
- Biological: Immunoglobulin Anti-RhD
- First Posted Date
- 2012-08-16
- Last Posted Date
- 2022-11-02
- Lead Sponsor
- Azidus Brasil
- Target Recruit Count
- 347
- Registration Number
- NCT01666249
- Locations
- 🇧🇷
Instituto Tropical de Medicina Reprodutiva e Menopausa -INTRO, Cuiaba, Mato Grosso, Brazil
🇧🇷Associação Educadora São Carlos AESC - Centro de Pesquisa HRPC, Canoas, Rio Grande Do Sul, Brazil
🇧🇷Hospital São Lucas (Puc-Rs), Porto Alegre, Rio Grande Do Sul, Brazil
PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Eritromax and Eprex, in Healthy Subjects.
Phase 1
- Conditions
- Healthy
- Interventions
- Drug: Epoetin Alfa
- First Posted Date
- 2012-08-14
- Last Posted Date
- 2012-08-14
- Lead Sponsor
- Azidus Brasil
- Target Recruit Count
- 80
- Registration Number
- NCT01664221
- Locations
- 🇧🇷
LAL Clinica, Valinhos, Sao Paulo, Brazil
PK and PD Study After Single Dose, Intravenous Administration of Two Epoetin Alfa, Eritromax and Eprex, in Healthy Subjects
Phase 1
- Conditions
- Healthy
- Interventions
- Drug: Epoetin Alfa
- First Posted Date
- 2012-08-14
- Last Posted Date
- 2012-08-14
- Lead Sponsor
- Azidus Brasil
- Target Recruit Count
- 28
- Registration Number
- NCT01664195
- Locations
- 🇧🇷
LAL Clínica, Valinhos, São Paulo, Brazil
PHARMACODYNAMICS ASSESSMENT PRODUCT HEPARIN SODIUM (SUBCUTANEOUSLY) OF THE SWINE 5.000UI/ML OF BLAU FARMACÊUTICA S/A IN HEALTHY SUBJECTS IN COMPARISON OF SODIUM HEPARIN APP PHARMACEUTICALS
- First Posted Date
- 2012-07-30
- Last Posted Date
- 2012-08-13
- Lead Sponsor
- Azidus Brasil
- Target Recruit Count
- 44
- Registration Number
- NCT01652638
- Locations
- 🇧🇷
LAL Clínica Pesquisa e Desenvolvimento Ltda., Valinhos, Brazil
PHARMACODYNAMICS ASSESSMENT PRODUCT HEPARIN SODIUM (INTRAVENOUSLY) OF THE SWINE 5.000UI/ML OF BLAU FARMACÊUTICA S/A IN HEALTHY SUBJECTS IN COMPARISON OF SODIUM HEPARIN APP PHARMACEUTICALS
- First Posted Date
- 2012-07-27
- Last Posted Date
- 2012-08-13
- Lead Sponsor
- Azidus Brasil
- Target Recruit Count
- 60
- Registration Number
- NCT01651923
- Locations
- 🇧🇷
LAL Clínica Pesquisa e Desenvolvimento Ltda., Valinhos, São Paulo, Brazil
© Copyright 2025. All Rights Reserved by MedPath